LipoScience to Present at Robert W. Baird & Co. Healthcare Conference

RALEIGH, N.C.--(BUSINESS WIRE)--LipoScience, Inc., an innovative diagnostic company developing proprietary clinical applications of nuclear magnetic resonance (NMR) spectroscopy, announced today that Richard O. Brajer, the company’s President and Chief Executive Officer, will be presenting at the Robert W. Baird & Co., Healthcare Conference at the St. Regis Hotel, NYC on September 15, 2010.

ABOUT LIPOSCIENCE, INC.

LipoScience is a highly innovative, diagnostic company focused on changing the way heart disease, diabetes and other metabolic diseases are assessed and managed.

LipoScience developed proprietary tests based on Nuclear Magnetic Resonance (NMR), an information-rich technology that produces a digital representation of the molecules present in a simple blood sample.

Over 5 million NMR LipoProfile® tests have been ordered by physicians. The test directly measures lipoprotein particles and provides physicians and their patients more information to manage their risk for heart disease and diabetes.

LipoScience is preparing to decentralize its proprietary platform with a broad array of high value NMR based assays, in support of driving toward new clinical standards of care.

For further information on the Company, please visit www.liposcience.com.